Nikki Blackwood was washing dishes on maternity leave when her corpse first finished creating what she was told. Right leg bent, the fingers tightened.

"I thought,' that's a little unusual. My corpse is preparing it, and I do not control it,” said the 35 - year-old mother and Manager of the investment Bank.

She noticed, actually what cleans your teeth, and scribble has become a struggle, such as her right hand went haphazard, and soon she began to apply the left hand to control her right.

When the neurologist asked her to walk down the hall, her right arm wouldn't swing.

The 3rd neurologist did not refute this. She had Parkinson's. "I was absolutely dumbfounded," said Miss Blackwood, who is now 36 years old. “It was a powerful shock.”

In the meantime, its signs are curable, but she is acutely aware of the increasing nature of the disease and its debilitating signs.

“I can only just believe, exactly what in the future will become a kind of important development," she said.

In the search for effective healing and elusive healing of Parkinson's Australian scientists will find out whether there are any chances to be medicines to slow the progression of degenerative conditions and to order the genomes of patients in order to demystify its prerequisites.

On Wednesday, Federal Minister of health Greg hunt will announce a $ 30 million allocation for the Parkinson's disease control goal, which brings together clinical trials and genomics studies under the management of the Garvan University of medical studies.

Approximately 1-2% of retired Australians are affected by Parkinson's disease, and within 5% of patients under the age of 40.

Not paying attention to the selfless studies conducted since the 1960s, the prerequisites for Parkinson's disease are largely unidentified, and healing only masks the signs. There is an urgent need to identify medicines that will slow down or stop the disease, Mr. hunt said.

During the first clinical review of the mission, 300 patients will be randomly provided with medicines for diabetes, asthma, cardiovascular diseases, supplements or placebo.

The main investigator, neurologist Dr. Simon Lewis said that the tests are required to provide patients with “realistic hope, not hype.” But the grandeur of the mission of Parkinson's disease was that it would combine clinical testing and” really wise science, " said Dr. Lewis.

Scientists will begin sequencing the genomes of people with Parkinson's disease in an attempt to detect unknown prerequisites, identify biomarkers and qualify whether there are subtypes of Parkinson's that have every chance of being targeted by certain medications, these like breast cancer.

"It is interesting that, in fact, that including if we find a drug that does not work, we all just know something about the disease," said Dr. Lewis.

“We may not find the drug, but we will get closer to it because of these efforts.”

The head of the program of neurodegeneration and Neurogenomics of the Garvan University, associate Professor Antony Cooper said, in fact, that this will be the first step to personalized medicine for people with Parkinson's disease.

"If we find that the product actually works for some patients, but not for others, we can find joint ways, find medicines that we already know, are aimed at these ways and see whether they work," said Dr. Cooper.

"If we can identify the disease much earlier and find a drug that will odernet its progression, these people never have a good chance to develop debilitating signs associated with Parkinson's disease."

Scientists will start a set of members on the 1st inspection in the 2nd half of the year.

Within 1000 patients will be involved in the direction of 5 years, and the Federal government will allocate $ 30 million from the upcoming Fund of medical studies.

"Many of us have seen how Parkinson's disease has done harm to our loved ones," said Mr. hunt.

“We know firsthand how important is the exploration of breakthrough healing, and just as a consequence of this, for example, relevant studies.”

Another $ 6.8 million. USA in the direction of 4 years will be remotely grids of primary health care support to facilitate access to special honey sisters in the community for people with movement disorders, encompassing Parkinson's disease.

According to the texts of Mr. hunt, nurses will provide clinical support, coordinate access to community proposals to conclude acute and acquired tasks with well-being and provide education and information.

The challenge of Parkinson's disease - is an international cooperation, under the office of Australia, established Garvan, Shake It Up Foundation Australia, Parkinson's Australia, The Cure Parkinson's Trust and the Foundation of Michael J. Fox. Fox for Parkinson's studies.